Gene detection quality control product as well as preparation method and application thereof
Through cross-linking technology based on biological matrix, genetic testing quality control products with uniformity and stability were prepared, which solved the problem that quality control products in the prior art was difficult to simulate the properties of clinical samples, and achieved efficient genetic testing quality control and Cost reduction.
Patent Information
- Application Number
- CN202411158015.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-22
- Publication Date
- 2024-11-26
AI Technical Summary
Existing genetic testing quality control products are difficult to simulate the properties of clinical FFPE samples, and the preparation process is complex and costly, which cannot meet the needs of large-scale production and application.
Using genetic testing quality control products based on biological matrix, a dense three-dimensional framework structure is formed through cross-linking, including cells, DNA or RNA carrying mutant genes, combined with amino acid polymers, cross-linking partners and cross-linking agents, to prepare uniform Paraffin embedded quality control products with stability and stability.
It realizes the uniformity, stability and biocompatibility of genetic testing quality control products, can simulate tissue structure, and is suitable for indoor quality control and inter-room quality evaluation of laboratory genetic testing, reducing detection costs and improving detection quality.
Smart Images

Figure CN119020458A_ABST
Abstract
Description
Technical Field
[0001] The present invention belongs to the fields of medical testing, precision medicine and biotechnology, and relates to a gene detection quality control product and its preparation method and application. Background Art
[0002] Precision medicine based on genetic testing can significantly improve treatment outcomes and patient quality of life, bringing significant benefits to patients. The use of quality control materials in routine genetic testing in laboratories is a crucial measure to ensure test quality. Formalin-fixed paraffin-embedded (FFPE) tissue is a key sample type for genetic testing. FFPE quality control materials prepared from patient tissue samples are ideal for genetic testing. However, due to limited sources, large-scale production and application are difficult, and ethical concerns make them unsuitable as a source of FFPE quality control materials. Currently, there are two main methods for preparing tissue quality control materials. One is to culture cell lines and then embed them in paraffin. This method produces tissue samples with a dispersed distribution and lacks organizational structure. Another method for preparing tissue quality control materials is to use xenograft tumor tissue generated by transplanting cell lines into immunodeficient mice. This quality control material can simulate human tissue structure and has good homogeneity and reproducibility. However, the preparation process is complex, making mass production difficult and costly, which limits its application in quality control applications.
[0003] Given the current limitations of FFPE quality controls, many laboratories rely solely on nucleic acid quality controls, such as commercially available DNA / RNA quality controls or laboratory-prepared DNA / RNA quality controls. However, these nucleic acid-based quality controls bypass the nucleic acid extraction step and are therefore not ideal quality controls.
[0004] CN111235225A discloses a paraffin-embedded (FFPE) reference product for detecting fusion gene RNA expression, and its preparation method and application. A single fusion gene cell line is prepared into an FFPE RNA reference product, or multiple fusion gene cell lines are mixed according to a set quantity ratio to prepare an FFPE RNA reference product. The obtained quality control product is not prepared based on a biological matrix, lacks tissue structure, and cannot approach the properties of clinical FFPE samples. Therefore, the preparation is close to the properties of clinical samples, can participate in nucleic acid extraction, effectively monitor the entire detection process, has good uniformity, stability and versatility, is easy to prepare, has good biocompatibility and is convenient and practical. It is of great significance to ensure the quality of laboratory genetic testing and improve the quality management level of the medical testing industry. Summary of the Invention
[0005] In response to the deficiencies of the existing technology and actual needs, the present invention provides a genetic testing quality control product, a preparation method, and an application thereof. The genetic testing quality control product of the present invention is based on a biological matrix, has a dense three-dimensional skeleton structure, good biocompatibility, can simulate tissue structure, and has good uniformity and stability.
[0006] In order to achieve the purpose of the invention, the present invention adopts the following technical solutions:
[0007] In a first aspect, the present invention provides a genetic testing quality control product, which includes any one of cells, DNA or RNA embedded in a biological matrix; the cells, DNA or RNA include cells, DNA or RNA carrying mutant genes and / or wild-type cells, DNA or RNA that do not carry mutant genes; the biological matrix includes an amino acid polymer, a cross-linking partner and a cross-linking agent.
[0008] The biomatrix in the present invention is a substance having a three-dimensional skeleton structure obtained by cross-linking.
[0009] The cells of the present invention include cells carrying gene mutations and / or cells not carrying gene mutations.
[0010] The genetic testing quality control product of the present invention is easy to prepare and is convenient and practical. It can monitor the entire genetic testing process starting from nucleic acid extraction and can be used for indoor quality control and external quality assessment of laboratory genetic testing to ensure the quality of testing. In addition, it can also be used in the preparation of DNA and RNA extraction kits and genetic testing kits.
[0011] The DNA in the present invention includes DNA carrying gene mutations and / or DNA not carrying gene mutations.
[0012] The RNA in the present invention includes RNA carrying gene mutations and / or RNA not carrying gene mutations.
[0013] Preferably, the amino acid polymer comprises any one of γ-polyglutamic acid, sodium γ-polyglutamate, polyaspartic acid or sodium polyaspartate, or a combination of at least two thereof.
[0014] Preferably, the cross-linking partner comprises any one of gelatin, collagen or hydrolyzed collagen, or a combination of at least two of them.
[0015] Preferably, the mass ratio of the amino acid polymer, the cross-linking partner and the cross-linking agent is (0.5-500):(0.25-250):1.
[0016] Preferably, the cross-linking agent comprises carbodiimide and / or hydroxysuccinimide.
[0017] Preferably, the biomatrix further comprises a support, and the support comprises gelatin and / or agarose.
[0018] Preferably, the mass ratio of the support, amino acid polymer, cross-linking partner and cross-linking agent is (5-500):(0.5-500):(0.25-250):1.
[0019] It can be understood that the support in the present invention is a material with a certain physical support strength, and also includes other substances that can play a supporting role, such as chitosan and other substances.
[0020] The support in the present invention may be in the form of particles or powder.
[0021] In a second aspect, the present invention provides a method for preparing the genetic testing quality control product described in the first aspect, the method comprising the following steps:
[0022] (1) mixing any one of cells, DNA or RNA with an amino acid polymer, a cross-linking partner and a cross-linking agent to obtain a cross-linked product, wherein the mass ratio of the amino acid polymer, the cross-linking partner and the cross-linking agent is (0.5-500):(0.25-250):1, and the cells, DNA or RNA include cells, DNA or RNA carrying a mutant gene and / or wild-type cells, DNA or RNA not carrying a mutant gene;
[0023] (2) fixing the cross-linked product in a neutral formalin fixative, and after rinsing, sequentially placing the cross-linked product in a 65-78% by mass ethanol solution, an 80-90% by mass ethanol solution, a 90-98% by mass ethanol solution, and anhydrous ethanol for dehydration;
[0024] (3) The dehydrated cross-linked product is placed in xylene and allowed to stand, and wax is impregnated with wax solution, and frozen and solidified to obtain a paraffin-embedded quality control wax block;
[0025] (4) Slice the quality control wax block to obtain paraffin-embedded quality control sections.
[0026] In one embodiment of the present invention, if the total volume increases or decreases, the amount of each component added is increased or decreased in equal proportion. For example, if the total volume is doubled in equal proportion, 0.01 to 1.0 g of amino acid polymer is weighed and dissolved in 1.6 mL of PBS buffer. The solution is shaken and fully dissolved to form a uniform solution. Then, 1.0 mL of a cross-linking partner solution with a concentration of 0.005 to 0.5 g / mL (the cross-linking partner is dissolved in PBS buffer) is added thereto. After thorough mixing, 0.4 mL of cell or DNA or RNA solution (the concentration of the cell solution is: 5×10 6 ~5×10 8 / mL; DNA or RNA solution concentration is 10-1000μg / mL), mix thoroughly, add 0.1-1.0g support, mix thoroughly, add 20-200μL of 0.1g / mL cross-linking agent (cross-linking agent dissolved in PBS buffer), mix thoroughly, and let stand for 1h to cross-link to form a cross-linked product.
[0027] The specific point values among the above 65-78% may be 65%, 68%, 70%, 72%, 76%, etc.
[0028] The specific point values in the above 80-90% can be selected from 80%, 82%, 84%, 88%, 90%, etc.
[0029] The specific point values among the above 90-98% may be 90%, 92%, 94%, 96%, 98%, etc.
[0030] Preferably, the mass percentage of the neutral formalin fixative is 8-15% (eg, 8%, 10%, or 12%).
[0031] Preferably, the fixed time in step (2) is 1-2 hours (for example, 1 hour, 1.5 hours, or 2 hours can be selected).
[0032] Preferably, the standing time in step (2) is 1-2 hours (for example, 1 hour, 1.5 hours, or 2 hours can be selected).
[0033] Preferably, the standing time in step (3) is 2-4 hours (for example, 2 hours, 3 hours, or 4 hours can be selected).
[0034] Preferably, the temperature of the wax liquid in step (3) is 60-70°C (for example, 60°C, 65°C, or 70°C can be selected).
[0035] Preferably, the wax dipping time in step (3) is 2-4 hours (for example, 2 hours, 3 hours, or 4 hours can be selected).
[0036] Preferably, the thickness of the quality control sample slice in step (4) is 4-20 μm (for example, 4 μm, 10 μm, or 20 μm can be selected).
[0037] In a third aspect, the present invention provides the use of the genetic testing quality control product described in the first aspect in laboratory internal quality control, external quality assessment, and preparation of DNA extraction kits, RNA extraction kits or genetic testing kits.
[0038] Compared with the prior art, the present invention has the following beneficial effects:
[0039] The genetic testing quality control product of the present invention is based on a biological matrix, has a dense three-dimensional skeleton structure, good biocompatibility, can simulate tissue structure, has good uniformity and stability, is easy to prepare, convenient and practical, can monitor the entire genetic testing process from nucleic acid extraction, is compatible with multiple genetic testing platforms such as qPCR, digital PCR, second-generation sequencing, FISH, etc., can be used for indoor quality control and external quality assessment of laboratory genetic testing to ensure detection quality, and can also be used in the preparation of DNA, RNA extraction kits and genetic testing kits. BRIEF DESCRIPTION OF THE DRAWINGS
[0040] Figure 1 This is a picture of the bio-based FFPE quality control product with a three-dimensional skeleton structure prepared by the present invention. DETAILED DESCRIPTION
[0041] To further illustrate the technical means and effects of the present invention, the present invention is further described below with reference to the embodiments and drawings. It should be understood that the specific embodiments described herein are only used to explain the present invention, rather than to limit the present invention.
[0042] If no specific techniques or conditions are specified in the examples, the experiments were carried out according to the techniques or conditions described in the literature in the field or according to the product instructions. If no manufacturer is specified for the reagents or instruments used, they are all conventional products that can be purchased through regular channels.
[0043] Example 1
[0044] Preparation of EGFR T790M gene mutation quality control product.
[0045] (1) Cell preparation: Both the EGFR T790M gene mutation cell line and the wild-type cell line without EGFR T790M gene mutation were cultured in FBS medium at 37°C and 5% carbon dioxide until the logarithmic growth phase. The two cells were collected by centrifugation, and 2 mL of PBS was added to each cell line. The cells were mixed by pipetting to form a cell suspension. The mutation of the EGFR T790M gene mutation cell line was confirmed by the Xinyi TD-1 digital PCR platform. For the specific operation steps, please refer to the instructions of the Xinyi EGFR T790M gene mutation detection kit. The two cells were mixed according to the calculated ratio to prepare gradient quality control products with EGFR T790M gene mutation frequencies of 0%, 2%, and 10%, respectively. The total number of mixed cells was 1×10 7 , suspended in 0.2 mL PBS, and pipetted to mix to form a cell suspension;
[0046] (2) Cross-linking: Weigh 3 portions of 0.1 g of γ-polyglutamic acid, dissolve them in 0.8 mL of PBS buffer, shake and mix, fully dissolve to form a uniform solution, add 0.5 mL of 0.1 g / mL gelatin solution (gelatin dissolved in PBS buffer) to each solution, mix thoroughly, add 0.2 mL of cell suspension with EGFR T790M gene mutation frequency of 0%, 2%, and 10% prepared in the previous step, mix thoroughly, add 0.2 g of gelatin particles (diameter 2 mm), mix thoroughly, add 30 μL of 0.1 g / mL carbodiimide cross-linker (cross-linker dissolved in PBS buffer), mix thoroughly, and let stand at 25°C for 1 h to cross-link to form a cross-linked product;
[0047] (3) Fixation and dehydration: The cross-linked products were spread flatly in separate embedding boxes, fixed in 50 mL of 10% neutral formalin fixative for 1 h, rinsed three times with PBS, placed in 100 mL of 75% ethanol solution, allowed to stand for 1 h, then removed, placed in 100 mL of 85% ethanol solution, allowed to stand for 1 h, then removed, placed in 100 mL of 95% ethanol solution, allowed to stand for 1 h (repeat twice), removed, placed in 100 mL of anhydrous ethanol, allowed to stand for 2 h (repeat twice), and removed;
[0048] (4) Paraffin embedding: Place the above-mentioned quality control sample after fixation and dehydration in 100 mL of xylene, let it stand for 2.5 hours, take it out, put it into 65°C wax solution and soak it in wax for 2.5 hours, take it out and place it in a wax box, inject 65°C wax solution into the wax box, and immediately place it on a freezing table for freezing and solidification to prepare a paraffin-embedded quality control sample wax block;
[0049] (5) Sectioning: The paraffin-embedded quality control sample was sectioned to a thickness of 10 μm to prepare paraffin-embedded quality control sample sections.
[0050] Example 2
[0051] Preparation of EGFR T790M gene mutation DNA level quality control product.
[0052] (1) DNA preparation: The EGFR T790M gene mutant cell line and the wild-type cells without EGFR T790M gene mutation cultured to the logarithmic growth phase in Example 1 were cultured to the logarithmic growth phase, and the two cells were collected by centrifugation. DNA was extracted using a DNA extraction kit (Tian Gen). The specific operation steps are shown in the kit instructions. The two DNAs were mixed according to the calculated ratio to prepare DNA gradient quality control products with EGFR T790M gene mutation frequencies of 0%, 2%, and 10%, respectively. The total amount of DNA in each DNA gradient quality control product was 10 μg, which was dissolved in 0.2 mL Tris-HCl buffer;
[0053] (2) Cross-linking: Weigh 3 portions of 0.1 g of sodium polyglutamate (γ-polyglutamate), dissolve them in 0.8 mL of PBS buffer, shake and mix, fully dissolve to form a uniform solution, add 0.5 mL of 0.1 g / mL gelatin solution (gelatin dissolved in PBS buffer) to each of them, mix thoroughly, add 0.2 mL of DNA solution with EGFR T790M gene mutation frequencies of 0%, 2%, and 10% prepared in the previous step, mix thoroughly, add 0.2 g of agarose powder, mix thoroughly, add 30 μL of 0.1 g / mL hydroxysuccinimide cross-linker (cross-linker dissolved in PBS buffer), mix thoroughly, and let stand at 25°C for 1 h to cross-link to form a cross-linked product;
[0054] (3) Fixation and dehydration: Spread the above-mentioned quality control samples flatly into independent embedding boxes, place them in 50 mL of 10% neutral formalin fixative for 1 h, rinse them with PBS three times, place them in 100 mL of 75% ethanol solution, let them stand for 1 h, then take them out, place them in 100 mL of 85% ethanol solution, let them stand for 1 h, then take them out, place them in 100 mL of 95% ethanol solution, let them stand for 1 h (repeat twice), take them out, place them in 100 mL of anhydrous ethanol, let them stand for 2 h (repeat twice), and take them out;
[0055] (4) Paraffin embedding: Place the above-mentioned quality control sample after fixation and dehydration in 100 mL of xylene, let it stand for 2.5 hours, take it out, put it into 65°C wax solution and soak it in wax for 2.5 hours, take it out and place it in a wax box, inject 65°C wax solution into the wax box, and immediately place it on a freezing table for freezing and solidification to prepare a paraffin-embedded quality control sample wax block;
[0056] (5) Sectioning: The paraffin-embedded quality control sample was sectioned to a thickness of 10 μm to prepare paraffin-embedded quality control sample sections.
[0057] Example 3
[0058] Preparation of quality control products for artificial vectors of EGFR T790M gene mutation.
[0059] (1) Preparation of artificial vectors: The pMD18-T plasmid carrying the EGFR T790M gene mutation and the pMD18-T plasmid carrying the EGFR wild-type sequence were transformed into E. coli DH5α competent cells, respectively, and cultured in LB liquid medium at 37°C until the logarithmic growth phase, followed by plasmid extraction. The two plasmids were mixed according to the calculated ratio to prepare pMD18-T plasmid gradient quality control products with EGFR T790M gene mutation frequencies of 0%, 2%, and 10%, respectively. The total amount of plasmid DNA in each gradient quality control product was 10 μg, dissolved in 0.2 mL Tris-HCl buffer;
[0060] (2) Cross-linking: Weigh 3 portions of 0.1 g of γ-polyglutamic acid, dissolve them in 0.8 mL of PBS buffer, shake and mix, fully dissolve to form a uniform solution, add 0.5 mL of 0.1 g / mL gelatin solution (gelatin dissolved in PBS buffer) to each of them, mix thoroughly, add 0.2 mL of the plasmid solution with EGFR T790M gene mutation frequencies of 0%, 2%, and 10% prepared in the previous step, mix thoroughly, add 0.3 g of gelatin particles (diameter 2 mm), mix thoroughly, add 30 μL of 0.1 g / mL carbodiimide cross-linker (cross-linker dissolved in PBS buffer), mix thoroughly, and let stand at 25°C for 1 h to cross-link to form a cross-linked product;
[0061] (3) Fixation and dehydration: Spread the above-mentioned quality control samples flatly into independent embedding boxes, place them in 50 mL of 10% neutral formalin fixative for 1 h, rinse them with PBS three times, place them in 100 mL of 75% ethanol solution, let them stand for 1 h, then take them out, place them in 100 mL of 85% ethanol solution, let them stand for 1 h, then take them out, place them in 100 mL of 95% ethanol solution, let them stand for 1 h (repeat twice), take them out, place them in 100 mL of anhydrous ethanol, let them stand for 2 h (repeat twice), and take them out;
[0062] (4) Paraffin embedding: Place the above-mentioned quality control sample after fixation and dehydration in 100 mL of xylene, let it stand for 2.5 hours, take it out, put it into 65°C wax solution and soak it in wax for 2.5 hours, take it out and place it in a wax box, inject 65°C wax solution into the wax box, and immediately place it on a freezing table for freezing and solidification to prepare a paraffin-embedded quality control sample wax block;
[0063] (5) Sectioning: The paraffin-embedded quality control sample was sectioned to a thickness of 10 μm to prepare paraffin-embedded quality control sample sections.
[0064] Example 4
[0065] Preparation of ALK gene fusion mutation RNA level quality control product.
[0066] (1) RNA preparation: Both the ALK gene fusion mutation cell line and the wild-type cell line were cultured in FBS medium at 37°C with 5% carbon dioxide until the logarithmic growth phase. The two cell lines were collected by centrifugation and RNA was extracted using an RNA extraction kit (Tiangen). The specific operation steps are shown in the kit instructions. The two RNAs were mixed according to the calculated ratio to prepare RNA gradient quality control products with ALK gene fusion mutation frequencies of 0%, 2%, and 10%, respectively. The total amount of RNA in each RNA gradient quality control product was 10 μg, which was dissolved in 0.2 mL Tris-HCl buffer;
[0067] (2) Cross-linking: Weigh 3 portions of 0.1 g of γ-polyglutamic acid, dissolve them in 0.8 mL of PBS buffer, shake and mix, fully dissolve to form a uniform solution, add 0.5 mL of 0.1 g / mL gelatin solution (gelatin dissolved in PBS buffer) to each solution, mix thoroughly, add 0.2 mL of RNA solution with ALK gene fusion mutation frequencies of 0%, 2%, and 10% prepared in the previous step, mix thoroughly, add 0.3 g of gelatin particles (2 mm in diameter), mix thoroughly, add 30 μL of 0.1 g / mL carbodiimide cross-linker (cross-linker dissolved in PBS buffer), mix thoroughly, and let stand at 25°C for 1 h to cross-link to form a cross-linked product;
[0068] (3) Fixation and dehydration: Spread the above-mentioned quality control samples flatly into independent embedding boxes, place them in 50 mL of 10% neutral formalin fixative for 1 h, rinse them with PBS three times, place them in 100 mL of 75% ethanol solution, let them stand for 1 h, then take them out, place them in 100 mL of 85% ethanol solution, let them stand for 1 h, then take them out, place them in 100 mL of 95% ethanol solution, let them stand for 1 h (repeat twice), take them out, place them in 100 mL of anhydrous ethanol, let them stand for 2 h (repeat twice), and take them out;
[0069] (4) Paraffin embedding: Place the above-mentioned quality control sample after fixation and dehydration in 100 mL of xylene, let it stand for 2.5 hours, take it out, put it into 65°C wax solution and soak it in wax for 2.5 hours, take it out and place it in a wax box, inject 65°C wax solution into the wax box, and immediately place it on a freezing table for freezing and solidification to prepare a paraffin-embedded quality control sample wax block;
[0070] (5) Sectioning: The paraffin-embedded quality control sample was sectioned to a thickness of 10 μm to prepare paraffin-embedded quality control sample sections.
[0071] Example 5
[0072] This embodiment provides a genetic testing quality control product, which differs from Example 1 in that it does not contain support gelatin particles.
[0073] Example 6
[0074] This embodiment provides a gene detection quality control product, which differs from Example 1 in that the biological matrix is γ-polyglutamic acid, collagen, and a cross-linking agent.
[0075] Example 7
[0076] This embodiment provides a genetic testing quality control product, which differs from Example 1 in that the biological matrix is polyaspartic acid, gelatin, and a cross-linking agent.
[0077] Example 8
[0078] The difference between this embodiment and embodiment 1 is that the biological matrix is γ-polyglutamic acid, pectin and a cross-linking agent.
[0079] Example 9
[0080] The difference between this embodiment and embodiment 1 is that the biological matrix is polyfructose, gelatin and a cross-linking agent.
[0081] Comparative Example 1
[0082] This comparative example provides a genetic testing quality control product, which differs from Example 1 only in that the biological matrix does not contain γ-polyglutamic acid, and its mass fraction is proportionally distributed to the gelatin and the cross-linking agent.
[0083] Comparative Example 2
[0084] This comparative example provides a genetic testing quality control product, which differs from Example 1 in that the biological matrix does not contain gelatin, and its mass fraction is proportionally distributed to γ-polyglutamic acid and the cross-linking agent.
[0085] Comparative Example 3
[0086] This comparative example provides a genetic testing quality control product, which differs from Example 1 in that the biological matrix does not contain a cross-linking agent, and its mass fraction is proportionally distributed to γ-polyglutamic acid and gelatin.
[0087] Test Example 1
[0088] Homogeneity verification.
[0089] FFPE quality control samples with different gene mutation frequencies prepared in the examples and comparative examples were randomly sampled from different parts, 5 consecutive sections were taken from each part, and the gene mutation frequency was detected using the Xinyi TD-1 digital PCR platform. The results are shown in Table 1.
[0090] Table 1
[0091]
[0092]
[0093] The results show that the measured mutation frequencies of the EGFR T790M gene detection quality control product obtained in Example 1 of the present invention are in line with expectations and fluctuate within a certain range, with CV values of <5%, indicating that the mutation frequencies at different slice positions are relatively stable, and the gene detection quality control product prepared in Example 1 has good uniformity. The DNA level quality control products, artificial vector quality control products, and RNA level quality control products prepared in Examples 2-4 of the present invention all have good uniformity. Example 5 does not contain support gelatin particles, and the resulting CV value is higher than the CV value of Example 1, indicating that the uniformity of the quality control product prepared in Example 5 is lower than that in Example 1. Examples 6-7 and Comparative Examples 1-3 illustrate that the biological matrix components of the genetic detection quality control product of the present invention have a synergistic effect in achieving the successful preparation of the quality control product and promoting the uniform performance of the quality control product. Examples 8 and 9 illustrate that a specific biological matrix combination is required to promote the uniform performance of the quality control product.
[0094] Test Example 2
[0095] Stability verification.
[0096] The FFPE quality control products with a gene mutation frequency of 10% prepared in the examples and comparative examples were placed at 25°C, and the DNA or RNA extraction amount was tested once every 2 weeks. Five consecutive sections of one part were randomly taken for testing each time. The FFPE DNA extraction kit (Tian Gen) or the FFPE RNA extraction kit (Tian Gen) was used to extract DNA or RNA from the FFPE sections. The extraction method and specific steps were referred to the kit instructions. The test was carried out continuously for 10 weeks. The results are shown in Table 2.
[0097] Table 2
[0098]
[0099]
[0100] The results show that the actual DNA extraction amount of the quality control product prepared in Example 1 was in line with expectations for 10 consecutive weeks, and the DNA extraction amount was relatively stable each time. After 10 weeks, the DNA extraction amount did not decrease significantly compared to the day of preparation, and the CV values were all <5%, indicating that the quality control product prepared in Example 1 has good stability and can be stored for a long time at 25°C. The DNA level quality control products, artificial carrier quality control products, and RNA level quality control products prepared in Examples 2-4 all have good stability. Example 5 does not contain support gelatin particles. As a result, the CV value of the DNA extraction amount is >6, and the DNA extraction amount decreased by 16% after 10 weeks, indicating that the support gelatin particles have a certain promoting effect on improving the stability of the quality control product. Examples 6-7 and Comparative Examples 1-3 illustrate that the biological matrix components of the genetic testing quality control products of the present invention have a synergistic effect in achieving the successful preparation of the quality control products and promoting the stability of the quality control products. Examples 8 and 9 illustrate that a specific biological matrix combination is required to promote the stability of the quality control products.
[0101] Test Example 3
[0102] Repeatability verification.
[0103] FFPE quality control samples with an EGFR T790M mutation frequency of 10% were prepared according to the preparation method of Example 1 for three consecutive days, with one batch prepared each day. Five random sections were taken from each batch of paraffin blocks, and five serial sections were taken from each section. DNA from the FFPE sections was extracted using the FFPE Nucleic Acid Extraction Kit (Tian Gen). The extraction method and specific steps were referred to the FFPE Nucleic Acid Extraction Kit manual. The amount of DNA extracted was calculated, and the mutation frequency of the extracted DNA was detected using the Xinyi TD-1 digital PCR platform. The results are shown in Table 3.
[0104] Table 3
[0105]
[0106] The results showed that the DNA extraction amount had good repeatability, with CV values of <5%. The mutation frequencies between randomly sampled sections at different positions in the same batch and the mutation frequencies of wax blocks between different batches were also relatively stable, with CV values of <5%. This indicates that the quality control product prepared in Example 1 has good intra-batch and inter-batch repeatability, a stable process, and can be produced in batches and on a large scale.
[0107] In summary, the genetic testing quality control product of the present invention has a dense three-dimensional skeleton structure, good biocompatibility, can simulate tissue structure, has good uniformity and stability, is easy to prepare, convenient and practical, can monitor the entire genetic testing process starting from nucleic acid extraction, and can be used for indoor quality control and inter-laboratory quality assessment of laboratory genetic testing to ensure the quality of testing.
[0108] The applicant states that the present invention is intended to illustrate the detailed methods of the present invention through the above-described embodiments, but the present invention is not limited to the above-described detailed methods, that is, it does not mean that the present invention must rely on the above-described detailed methods in order to be implemented. Those skilled in the art should understand that any improvements to the present invention, equivalent substitutions for various raw materials in the products of the present invention, addition of auxiliary ingredients, and selection of specific methods, etc., are all within the scope of protection and disclosure of the present invention.
Claims
1. A gene detection quality control product, characterized in that: The gene detection quality control product includes any one of cells, DNA or RNA embedded in a biological matrix; The cells, DNA or RNA include cells, DNA or RNA carrying mutant genes and / or wild-type cells, DNA or RNA not carrying mutant genes; The biological matrix includes amino acid polymers, a cross-linking partner and a cross-linking agent.
2. The gene detection quality control product according to claim 1, characterized in that: The amino acid polymer includes any one of γ-polyglutamic acid, sodium γ-polyglutamate, polyaspartic acid or sodium polyaspartate, or a combination of at least two thereof.
3. The gene detection quality control product according to claim 1 or 2, characterized in that: The cross-linking partner includes any one of gelatin, collagen or hydrolyzed collagen or a combination of at least two thereof; Preferably, the mass ratio of the amino acid polymer, the cross-linking partner and the cross-linking agent is (0.5-500):(0.25-250):
1.
4. The gene detection quality control product according to any one of claims 1 to 3, characterized in that: The cross-linking agent includes carbodiimide and / or hydroxysuccinimide.
5. The gene detection quality control product according to any one of claims 1 to 4, characterized in that: The biomatrix further comprises a support, wherein the support comprises gelatin and / or agarose; Preferably, the mass ratio of the support, the amino acid polymer, the cross-linking partner and the cross-linking agent is (5-500):(0.5-500):(0.25-250):
1.
6. A method for preparing a gene detection quality control product according to any one of claims 1 to 5, characterized in that: The method comprises the following steps: (1) mixing any one of cells, DNA or RNA with an amino acid polymer, a cross-linking partner and a cross-linking agent to obtain a cross-linked product, wherein the mass ratio of the amino acid polymer, the cross-linking partner and the cross-linking agent is (0.5-500):(0.25-250):1, and the cells, DNA or RNA include cells, DNA or RNA carrying mutant genes and / or wild-type cells, DNA or RNA not carrying mutant genes; (2) fixing the cross-linked product in a neutral formalin fixative, and after washing, sequentially placing the cross-linked product in a 65-78% by mass ethanol solution, an 80-90% by mass ethanol solution, a 90-98% by mass ethanol solution, and anhydrous ethanol for dehydration; (3) The dehydrated cross-linked product is placed in xylene and allowed to stand, and wax is impregnated with wax liquid, and frozen and solidified to obtain a paraffin-embedded quality control wax block; (4) Slice the quality control wax block to obtain paraffin-embedded quality control sections.
7. The method according to claim 6, characterized in that The mass percentage of the neutral formalin fixative is 8-15%; Preferably, the fixing time in step (2) is 1-2 hours; Preferably, the standing time in step (2) is 1-2 hours.
8. The method according to claim 6 or 7, characterized in that: The standing time in step (3) is 2-4 hours; Preferably, the temperature of the wax liquid in step (3) is 60-70°C; Preferably, the wax dipping time in step (3) is 2-4 hours.
9. The method according to any one of claims 6 to 8, characterized in that: The thickness of the quality control sample slice in step (4) is 4-20 μm.
10. Use of the gene detection quality control product according to any one of claims 1 to 5 in laboratory internal quality control, external quality assessment, and preparation of DNA extraction kits, RNA extraction kits or gene detection kits.
